Cargando…

What’s in an intron? CCN1 mRNA splicing in cancer

The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested....

Descripción completa

Detalles Bibliográficos
Autor principal: Leask, Andrew
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721082/
https://www.ncbi.nlm.nih.gov/pubmed/19381874
http://dx.doi.org/10.1007/s12079-009-0050-x
_version_ 1782170168571461632
author Leask, Andrew
author_facet Leask, Andrew
author_sort Leask, Andrew
collection PubMed
description The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested. In a recent report, Hirschfeld and colleagues (Cancer Res 69:2082-90, 2009), show that CCN1 (cyr61) mRNA is normally present in a form in which intron 3 is retained. In cancers, or upon hypoxia, intron 3 is removed resulting in the appearance of CCN1 protein. The significance of this paper is discussed.
format Text
id pubmed-2721082
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-27210822009-08-06 What’s in an intron? CCN1 mRNA splicing in cancer Leask, Andrew J Cell Commun Signal Bits and Bytes The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested. In a recent report, Hirschfeld and colleagues (Cancer Res 69:2082-90, 2009), show that CCN1 (cyr61) mRNA is normally present in a form in which intron 3 is retained. In cancers, or upon hypoxia, intron 3 is removed resulting in the appearance of CCN1 protein. The significance of this paper is discussed. Springer Netherlands 2009-04-21 2009-06 /pmc/articles/PMC2721082/ /pubmed/19381874 http://dx.doi.org/10.1007/s12079-009-0050-x Text en © The Author(s) 2009
spellingShingle Bits and Bytes
Leask, Andrew
What’s in an intron? CCN1 mRNA splicing in cancer
title What’s in an intron? CCN1 mRNA splicing in cancer
title_full What’s in an intron? CCN1 mRNA splicing in cancer
title_fullStr What’s in an intron? CCN1 mRNA splicing in cancer
title_full_unstemmed What’s in an intron? CCN1 mRNA splicing in cancer
title_short What’s in an intron? CCN1 mRNA splicing in cancer
title_sort what’s in an intron? ccn1 mrna splicing in cancer
topic Bits and Bytes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721082/
https://www.ncbi.nlm.nih.gov/pubmed/19381874
http://dx.doi.org/10.1007/s12079-009-0050-x
work_keys_str_mv AT leaskandrew whatsinanintronccn1mrnasplicingincancer